Abstract
Leukotrienes (LTs) are a group of biologically highly potent mediators of inflammation, synthesised in the first metabolic step by 5-lipoxygenase from 20 carbon fatty acids, predominantly arachidonic acid. They include the cysteinyl leukotrienes LTC4, LTD4, LTE4, which cause bronchoconstriction, chemotaxis and enhanced blood vessel-permeability, and therefore play a major role in asthma, and the dihydroxyeicosatetraenoate LTB4, an important mediator for acute and chronic inflammatory ailments. Inhibition of leukotriene biosynthesis therefore is a promising target for combating a number of diseases. Plant secondary metabolites offer a structurally very diverse potential source of new therapeutic leads. The aim of this review is to update the current knowledge of plant compounds with inhibitory effects on leukotriene metabolism, by presenting results published in the last seven years. Substances are presented with their IC50 values together with the activities of the positive controls to enable better comparability. Inhibitory effects of extracts are not discussed.
Keywords: Kniphofia foliosa, Clerodane Type Diterpenes, FLAP inhibitors, Atractylodes lancea, Polyprenylated Hydroquinones, Maesanin
Current Organic Chemistry
Title: Inhibition of Leukotriene Biosynthesis by Secondary Plant Metabolites
Volume: 12 Issue: 8
Author(s): Michael Adams and Rudolf Bauer
Affiliation:
Keywords: Kniphofia foliosa, Clerodane Type Diterpenes, FLAP inhibitors, Atractylodes lancea, Polyprenylated Hydroquinones, Maesanin
Abstract: Leukotrienes (LTs) are a group of biologically highly potent mediators of inflammation, synthesised in the first metabolic step by 5-lipoxygenase from 20 carbon fatty acids, predominantly arachidonic acid. They include the cysteinyl leukotrienes LTC4, LTD4, LTE4, which cause bronchoconstriction, chemotaxis and enhanced blood vessel-permeability, and therefore play a major role in asthma, and the dihydroxyeicosatetraenoate LTB4, an important mediator for acute and chronic inflammatory ailments. Inhibition of leukotriene biosynthesis therefore is a promising target for combating a number of diseases. Plant secondary metabolites offer a structurally very diverse potential source of new therapeutic leads. The aim of this review is to update the current knowledge of plant compounds with inhibitory effects on leukotriene metabolism, by presenting results published in the last seven years. Substances are presented with their IC50 values together with the activities of the positive controls to enable better comparability. Inhibitory effects of extracts are not discussed.
Export Options
About this article
Cite this article as:
Adams Michael and Bauer Rudolf, Inhibition of Leukotriene Biosynthesis by Secondary Plant Metabolites, Current Organic Chemistry 2008; 12 (8) . https://dx.doi.org/10.2174/138527208784577349
DOI https://dx.doi.org/10.2174/138527208784577349 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Updates on Biological Activities of Oxadiazoles
Mini-Reviews in Medicinal Chemistry Community-Acquired Pneumonia in Children
Recent Patents on Inflammation & Allergy Drug Discovery Novel Therapeutic Agents Against Cancer Stem Cells of Chronic Myeloid Leukemia
Anti-Cancer Agents in Medicinal Chemistry The Role of Heme Oxygenase-1 in T Cell-Mediated Immunity: The All Encompassing Enzyme
Current Pharmaceutical Design Allergen Homologues, Pathogenesis-Related 1, Polygalacturonase, and Pectin Methyl Esterase from a Japanese Hop
Protein & Peptide Letters Editorial [Hot Topic: Oxidative Balance: Experimental and Clinical Perspectives (Executive Editor: Fortunato Vesce)]
Current Pharmaceutical Design Chemical and Pharmacological Significance of Natural Guanidines from Marine Invertebrates
Mini-Reviews in Medicinal Chemistry Cytokines as a Therapeutic Target for Allergic Diseases: A Complex Picture
Current Pharmaceutical Design Room Temperature Metal-Free Synthesis of Aryl/Heteroaryl-Substituted Bis(6-aminouracil-5-yl)methanes Using Sulfamic Acid (NH2SO3H) as an Efficient and Eco-friendly Organo-Catalyst
Current Organocatalysis Strategies to Convert PACAP from a Hypophysiotropic Neurohormone Into a Neuroprotective Drug
Current Pharmaceutical Design Diabetes Mellitus: Novel Insights, Analysis and Interpretation of Pathophysiology and Complications Management with Imidazole-Containing Peptidomimetic Antioxidants
Recent Patents on Drug Delivery & Formulation Putting Evidence for Diabetes Care into Practice
Current Diabetes Reviews Anticancer Properties of Asian Water Monitor Lizard (Varanus salvator), Python (Malayopython reticulatus) and Tortoise (Cuora kamaroma amboinensis)
Anti-Cancer Agents in Medicinal Chemistry Treating Neonatal Brain Injury - Promise and Inherent Research Challenges
Recent Patents on Inflammation & Allergy Drug Discovery Concurrent Use of Antiretrovirals and Anticonvulsants in Human Immunodeficiency Virus (HIV) Seropositive Patients
Current Pharmaceutical Design Therapeutic Use of Chemokines
Current Pharmaceutical Design Targeting Matrix Metalloproteinases in Inflammatory Conditions
Current Drug Targets Pharmacological Potential of Tetrahydrofurano/Pyrano Quinoline and Benzo[b]furoindolyl Derivatives in Acute Inflammation, Pain and Oxidative Stress
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Inhibitory effects of the Food Azo Dyes on Pig Liver Carboxylesterase Activity
Current Enzyme Inhibition Impact of Antibiotics on the Intestinal Microbiota and on the Treatment of Shiga-toxin-Producing Escherichia coli and Salmonella Infections
Current Pharmaceutical Design